News from savient pharmaceuticals, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Dec 13, 2013, 12:07 ET

Savient Receives Approval From Bankruptcy Court To Sell Substantially All Assets To Crealta Pharmaceuticals

 Savient Pharmaceuticals, Inc. (OTC: SVNTQ) ("Savient") announced today that it has received approval from the U.S. Bankruptcy Court for the...

Dec 11, 2013, 07:00 ET

Savient Reaches Agreement To Sell Substantially All Assets To Crealta Pharmaceuticals

 Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) ("Savient") announced today that it has reached agreement on the terms of an acquisition...

Dec 10, 2013, 00:28 ET

Savient Reaches Agreement On Use Of Cash Collateral

Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) ("Savient") announced today that an agreement in principle has been reached by and among Savient, the...

Oct 16, 2013, 16:51 ET

Savient Receives Court Approval Of Key "First Day" Motions

Savient Pharmaceuticals, Inc. (NASDAQ: SVNT)("Savient") announced today the approval of its "first day" motions by the U.S. Bankruptcy Court for...

Oct 14, 2013, 19:46 ET

Savient Pharmaceuticals Commences Voluntary Chapter 11 Proceeding; Seeks To Conduct Auction And Sale Under Section 363

Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) ("Savient") announced today that it has elected to file voluntary petitions under Chapter 11 of the...

Oct 08, 2013, 08:30 ET

Savient Pharmaceuticals Announces Abstract Related To KRYSTEXXA® Accepted For Presentation At ASN Kidney Week 2013

 Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) announced today that an abstract related to KRYSTEXXA® (pegloticase) has been selected...

Oct 03, 2013, 16:35 ET

Savient Announces Multiple Abstracts Related to KRYSTEXXA® to be Presented at the 2013 ACR/ARHP Annual Meeting

Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) today announced that several abstracts related to KRYSTEXXA® (pegloticase) have been...

Aug 14, 2013, 07:00 ET

Savient Pharmaceuticals Reports Second Quarter 2013 Financial Results

 Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) today reported financial results for the three and six-month periods ended June 30, 2013. ...

Jun 20, 2013, 16:05 ET

Savient Pharmaceuticals Announces Formation of Office of the President

Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) announced today that it has formed an Office of the President, consisting of Richard Crowley, who will...

Jun 12, 2013, 08:00 ET

Savient Pharmaceuticals to Present New KRYSTEXXA® Data at the 2013 European League Against Rheumatism (EULAR) Congress

 Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) today announced that ongoing KRYSTEXXA® (pegloticase) post-marketing surveillance data...

May 22, 2013, 13:38 ET
Today is Gout Awareness Day! Tweet your gout experiences with #NotJustGout.  (PRNewsFoto/Savient Pharmaceuticals, Inc.)

Jim Belushi, Savient And CreakyJoints Team Up To Shift The Conversation About Gout

Jim Belushi, Savient Pharmaceuticals and patient advocacy group CreakyJoints have released a new online video to encourage candid discussion...

May 15, 2013, 07:00 ET

Savient Pharmaceuticals Reports First Quarter 2013 Financial Results

 Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) today reported financial results for the three months ended March 31, 2013.  Net sales of...

Mar 19, 2013, 07:00 ET

Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2012 Financial Results

 Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) today reported financial results for the three months and full year ended December 31,...

Feb 26, 2013, 08:30 ET

Savient Pharmaceuticals to Hold Fourth Quarter and Year-End 2012 Financial Results Conference Call on Tuesday, March 19, 2013

 Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) announced today that the Company's fourth quarter and year-end 2012 financial results will be...

Feb 19, 2013, 08:30 ET

Sobi and Savient Pharmaceuticals Announce Co-Promotion Agreement for Kineret® (anakinra) in the U.S.

 Sobi (STO: SOBI) and Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) announced today that they have entered into an agreement for the...

Jan 08, 2013, 11:42 ET

Savient's KRYSTEXXA® (pegloticase) Receives European Commission Marketing Authorization for the Treatment of Certain Patients with Chronic Tophaceous Gout

Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) and its wholly owned subsidiary, Savient Pharma Ireland Ltd., today announced that the European...

Jan 08, 2013, 08:30 ET

Savient Pharmaceuticals Announces the Election of Genzyme CEO Dr. David Meeker to Its Board of Directors

 Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) announced today that David Meeker, M.D., President and Chief Executive Officer of Genzyme, a...

Jan 04, 2013, 08:30 ET

Savient Pharmaceuticals to Present at the 31st Annual J.P. Morgan Healthcare Conference

 Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) today announced that Lou Ferrari, President and Chief Executive Officer, will present at the 31st...

Dec 05, 2012, 08:30 ET

Savient Announces the Election of Robert G. Savage to its Board of Directors

 Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) today announced that Robert (Bob) G. Savage has been elected to the Company's Board of Directors,...

Nov 13, 2012, 08:00 ET

New Data Demonstrate KRYSTEXXA®-Treated Refractory Chronic Gout Patients Experienced Significantly Improved Health-Related Quality of Life

 Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) today announced results from new post-hoc analyses of KRYSTEXXA® (pegloticase) pivotal Phase...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Investor-Edge